A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics
- PMID: 6640008
A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics
Abstract
A quantitative study of the melanin-containing dopaminergic neurons of the nigrostriatal system (A 9) and of the mesolimbic system (A 10) was carried out on Nissl-stained serial sections of nine normal brains, six age-matched brains of schizophrenics, five brains of paralysis agitans, and six brains of postencephalitic parkinsonism. By contrast with most laboratory animals the A 10 cell group is not well developed in the human brain. Both in Parkinson's disease with a known hypoactivity of dopamine neurons and in schizophrenia with a postulated hyperfunction of these systems, pathological alterations of the dopamine cell groups can be observed. In paralysis agitans the nigrostriatal and the mesolimbic cell groups exhibit a significant loss of neurons, while the remaining mesolimbic cells appear to be in better condition. In the postencephalitic parkinsonism both systems have almost completely disappeared with a significant loss of nerve and glial cells. In schizophrenia there is a significant decrease in the volume of the nigrostriatal area. Here the mean volume of the glial nuclei is reduced, whereas the mean volume of the nerve cells is diminished in the mesolimbic part.
Similar articles
-
Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization.Ann Neurol. 1989 Oct;26(4):507-14. doi: 10.1002/ana.410260403. Ann Neurol. 1989. PMID: 2817827
-
Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.Ann Neurol. 1995 Mar;37(3):300-12. doi: 10.1002/ana.410370306. Ann Neurol. 1995. PMID: 7695230
-
Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?Neurobiol Dis. 2007 Jan;25(1):134-49. doi: 10.1016/j.nbd.2006.08.021. Epub 2006 Oct 18. Neurobiol Dis. 2007. PMID: 17055279
-
Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.Ann Neurol. 2003;53 Suppl 3:S135-46; discussion S146-8. doi: 10.1002/ana.10482. Ann Neurol. 2003. PMID: 12666105 Review.
-
The enigma of neuromelanin in Parkinson's disease substantia nigra.J Neural Transm Suppl. 1994;43:113-22. J Neural Transm Suppl. 1994. PMID: 7884393 Review.
Cited by
-
Effects of two commonly found strains of influenza A virus on developing dopaminergic neurons, in relation to the pathophysiology of schizophrenia.PLoS One. 2012;7(12):e51068. doi: 10.1371/journal.pone.0051068. Epub 2012 Dec 10. PLoS One. 2012. PMID: 23251423 Free PMC article.
-
Reduced Midbrain Dopamine Neuron Number in the Adult Non-human Primate Brain after Fetal Radiation Exposure.Neuroscience. 2020 Aug 21;442:193-201. doi: 10.1016/j.neuroscience.2020.07.005. Epub 2020 Jul 11. Neuroscience. 2020. PMID: 32659340 Free PMC article.
-
Essential aspects of the research problem in schizophrenia.J R Soc Med. 1988 Dec;81(12):691-7. doi: 10.1177/014107688808101205. J R Soc Med. 1988. PMID: 3065497 Free PMC article. Review. No abstract available.
-
Selective loss of nigral neurons in Alzheimer's disease: a morphometric study.Acta Neuropathol. 1992;83(3):271-6. doi: 10.1007/BF00296789. Acta Neuropathol. 1992. PMID: 1373022
-
Possible mechanisms of neurodegeneration in schizophrenia.Neurochem Res. 2006 Oct;31(10):1279-94. doi: 10.1007/s11064-006-9162-3. Epub 2006 Sep 28. Neurochem Res. 2006. PMID: 17006758 Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical